Lardacein: Difference between revisions
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
(No difference)
|
Latest revision as of 16:47, 9 August 2012
WikiDoc Resources for Lardacein |
Articles |
---|
Most recent articles on Lardacein |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Lardacein at Clinical Trials.gov Clinical Trials on Lardacein at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Lardacein
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Lardacein Discussion groups on Lardacein Directions to Hospitals Treating Lardacein Risk calculators and risk factors for Lardacein
|
Healthcare Provider Resources |
Causes & Risk Factors for Lardacein |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Lardacein is a protein found in tissues affected with amyloid degeneration. It is insoluble in nearly all reagents, is not acted upon by gastric juice, and is not readily subject to putrefaction. It gives a brown color when treated with iodine and sulfuric acid.
References
- Dorland's Illustrated Medical Dictionary (Twenty-sixth Edition) (ISBN 0-7216-1645-3)